Skip to content

US · LFST · MEDICAL - CARE FACILITIES

LifeStance Health Group, Inc. (LFST) intrinsic value and stock valuation

$13.82as of 2026-11-21 · Mkt cap 4.2B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

LifeStance Health Group, Inc. DCF and intrinsic value

InvestorsCraft values LFST with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from LFST’s statements →

LifeStance Health Group, Inc. Graham Number

Graham Number: $1.49d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Scottsdale, AZ 85251 lifestance.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$1.42B+30.4% 5y CAGRd
20192025
Net income
$9.66M
20192025
Free cash flow
$110M
20192025
Total equity
$1.52B+8.8% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$1.42B$1.25B$1.06B$859.5M$667.5M
Operating income$24.2M-$-31.61M-$-189.13M-$-210.17M-$-286.35M
Net income$9.66M-$-57.44M-$-186.26M-$-215.56M-$-307.2M
EPSd$24.7K-$-151.5K-$-506.89K-$-606.73K-$-937.96K
Operating cash flow$146.2M$107.3M-$-16.88M$52.8M$9.42M
Capital expenditure-$-36.12M-$-21.57M-$-40.52M-$-79.25M-$-94.49M
Free cash flow$110M$85.7M-$-57.4M-$-26.47M-$-85.07M
Total assets$2.2B$2.12B$2.11B$2.17B$1.93B
Total debt$194.1M$485.2M$511M$478.8M$158.7M
Net debt-$-54.55M$330.6M$432.2M$370.2M$10.7M
Total equity$1.52B$1.45B$1.43B$1.52B$1.55B
Cash and short-term investments$248.6M$154.6M$78.8M$108.6M$148M
Income statement
20252024202320222021
Revenue$1.42B$1.25B$1.06B$859.5M$667.5M
Cost of revenue$963.2M$848.6M$753.6M$622.5M$466M
Gross profit$461.1M$402.4M$302.1M$237M$201.5M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$382.2M$363.1M$410.8M$378M$433.7M
Other expenses$54.8M$71M$80.4M$69.2M$54.1M
Operating expenses$437M$434M$491.2M$447.2M$487.9M
Cost and expenses$1.4B$1.28B$1.24B$1.07B$953.9M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$11.7M$26.5M$21.2M$19.9M$38.9M
Depreciation and amortization$54.8M$71M$80.4M$69.2M$54.1M
Ebitda$78.8M$39.9M-$-104.93M-$-143.6M-$-240.06M
Operating income$24.2M-$-31.61M-$-189.13M-$-210.17M-$-286.35M
Total other income/expenses, net-$-11.79M-$-26M-$-17.45M-$-22.56M-$-46.75M
Income before tax$12.4M-$-57.61M-$-206.58M-$-232.73M-$-333.11M
Income tax expense$2.7M-$-170K-$-20.32M-$-17.17M-$-25.91M
Net income$9.66M-$-57.44M-$-186.26M-$-215.56M-$-307.2M
Weighted average shares outstanding$386M$379.2M$367.5M$355.3M$327.5M
Weighted average diluted shares outstanding$391.1M$379.2M$367.5M$355.3M$327.5M
Balance sheet
20252024202320222021
Cash and short-term investments$248.6M$154.6M$78.8M$108.6M$148M
Net receivables$95.7M$132M$125.6M$101.5M$99.3M
Inventory$0.00$0.00$0.00$0.00$38.1M
Total current assets$416.2M$312.5M$225.7M$233.2M$266.5M
Property, plant and equipment, net$311.3M$313.9M$358.9M$393.6M$152.2M
Goodwill and intangible assets$1.47B$1.48B$1.51B$1.54B$1.5B
Long-term investments$0.00$0.00$0.00$0.00-$-42.56M
Total non-current assets$1.79B$1.81B$1.88B$1.94B$1.66B
Total assets$2.2B$2.12B$2.11B$2.17B$1.93B
Accounts payable$6.12M$7.24M$23.2M$24.4M$14.2M
Short-term debt$45.5M$56.7M$49.4M$41.2M$1.32M
Deferred revenue$0.00$0.00$0.00$0.00$76.1M
Total current liabilities$252M$228.9M$202.9M$176M$116.8M
Long-term debt$148.6M$428.5M$461.6M$437.7M$157.4M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$431M$443.1M$478.2M$479.2M$265.3M
Capital lease obligations$0.00$198.2M$227.8M$251.4M$0.00
Total liabilities$682.9M$672M$681M$655.2M$382.1M
Common stock$3.88M$3.83M$3.79M$3.76M$3.74M
Retained earnings-$-808.63M-$-818.29M-$-760.85M-$-572.64M-$-357.07M
Accumulated other comprehensive income (loss)$0.00$930K$2.3M$3.27M$0.00
Total equity$1.52B$1.45B$1.43B$1.52B$1.55B
Total investments$0.00$0.00$0.00$0.00-$-42.56M
Total debt$194.1M$485.2M$511M$478.8M$158.7M
Net debt-$-54.55M$330.6M$432.2M$370.2M$10.7M
Cash flow statement
20252024202320222021
Net income$9.66M-$-57.44M-$-186.26M-$-215.56M-$-307.2M
Depreciation and amortization$54.8M$71M$80.4M$69.2M$54.1M
Stock-based compensation$74.7M$76.2M$99.4M$187.4M$259.4M
Change in working capital-$-40.34M-$-27.37M-$-33.72M-$-16.94M$2.14M
Accounts receivable$36.1M-$-6.4M-$-24.18M-$-21.66M-$-24.21M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-1.56M$500K-$-5.61M$7.67M$620K
Net cash provided by operating activities$146.2M$107.3M-$-16.88M$52.8M$9.42M
Investments in property, plant and equipment-$-36.12M-$-21.57M-$-40.52M-$-79.25M-$-94.49M
Acquisitions, net$0.00$0.00-$-19.82M-$-60.21M-$-99.58M
Net cash used for investing activities-$-36.12M-$-21.57M-$-60.34M-$-139.46M-$-194.08M
Common stock issued$0.00$0.00$0.00$0.00$549.9M
Common stock repurchased$0.00$0.00$0.00-$-900K$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-15.96M-$-9.95M$47.4M$47.3M$313.9M
Net change in cash$94.1M$75.8M-$-29.8M-$-39.41M$129.2M
Cash at end of period$248.6M$154.6M$78.8M$108.6M$148M
Operating cash flow$146.2M$107.3M-$-16.88M$52.8M$9.42M
Capital expenditure-$-36.12M-$-21.57M-$-40.52M-$-79.25M-$-94.49M
Free cash flow$110M$85.7M-$-57.4M-$-26.47M-$-85.07M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About LifeStance Health Group, Inc.

        LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.

        CEO
        David Patrick Bourdon
        Employees
        10.96K
        Beta
        1.12

        Explore

        Frequently asked questions

        What is the intrinsic value of LifeStance Health Group, Inc. (LFST)?

        LifeStance Health Group, Inc. (LFST) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is LFST undervalued?

        LFST trades at a price of $13.82 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.